(Q71859363)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605588%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonist (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605588%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

M. S. Starr

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7605588

10 June 2024

B. S. Starr

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7605588

10 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7605588

10 June 2024

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605588%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

http://link.springer.com/content/pdf/10.1007/BF02252961.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF02252961/fulltext.html

10 June 2024

1 reference

http://link.springer.com/content/pdf/10.1007/BF02252961

10 June 2024

1 reference

Journal of neural transmission. Parkinson's disease and dementia section

10 June 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605588%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605588%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605588%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

31-43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605588%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02252961

21 October 2019

exact match

0 references

cites work

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

2

1 reference

Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels

10 June 2024

3

1 reference

Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate

10 June 2024

4

1 reference

Studies on the mechanism of action of amantadine

10 June 2024

5

1 reference

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

10 June 2024

6

1 reference

Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice

10 June 2024

7

1 reference

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

10 June 2024

8

1 reference

Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels

10 June 2024

9

1 reference

The effect of amantadine on the uptake of dopamine and noradrenaline by rat brain homogenates.

10 June 2024

10

1 reference

Pharmacological changes in dopaminergic systems induced by long-term administration of amantadine

10 June 2024

11

1 reference

Excitatory amino acid antagonists and Parkinson's disease

10 June 2024

12

1 reference

Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801

10 June 2024

13

1 reference

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease

10 June 2024

14

1 reference

Evaluation of amantadine as a releasing agent or uptake blocker for H3-dopamine in rat brain slices

10 June 2024

15

1 reference

Amantadine and D-145, an amantadine derivative, do not effect dopamine sensitive adenylate cyclase from the caudate-putamen of the rat brain.

10 June 2024

17

1 reference

Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease

10 June 2024

18

1 reference

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

10 June 2024

19

1 reference

The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys

10 June 2024

20

1 reference

Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

10 June 2024

21

1 reference

The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems

10 June 2024

22

1 reference

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

10 June 2024

23

1 reference

The effect of amantadine on motor activity and catalepsy in rats

10 June 2024

25

1 reference

Nomifensine but not amantadine increases dopamine-induced responses on rat substantia nigra zona compacta neurons.

10 June 2024

26

1 reference

Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

10 June 2024

28

1 reference

MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease

10 June 2024

29

1 reference

Common and uncommon behavioural effects of antagonists for different modulatory sites in the NMDA receptor/channel complex.

10 June 2024

31

1 reference

Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect

10 June 2024

32

1 reference

Amantadine may stimulate dopamine and noradrenaline receptors

10 June 2024

33

1 reference

Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment.

10 June 2024

34

1 reference

The central effects of a novel dopamine agonist

10 June 2024

36

1 reference

Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors

10 June 2024

37

1 reference

Facilitation of dopamine D1 receptor- but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse

10 June 2024

38

1 reference

Glutamate antagonists modify the motor stimulant actions of D1 and D2 agonists in reserpine-treated mice in complex ways that are not predictive of their interactions with the mixed D1/D2 agonist apomorphine

10 June 2024

39

1 reference

The new competitive NMDA receptor antagonist CGP 40116 inhibits pilocarpine-induced limbic motor seizures and unconditioned motor behaviour in the mouse

10 June 2024

40

1 reference

Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice

10 June 2024

41

1 reference

Evidence for a non-dopaminergic action of amantadine

10 June 2024

42

1 reference

The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way

10 June 2024

43

1 reference

Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice

10 June 2024

44

1 reference

Potentiation by amantadine hydrochloride of L-dopa-induced effects in mice.

10 June 2024

45

1 reference

Dopamine: Release from the Brain in vivo by Amantadine

10 June 2024

46

1 reference

Sites for Antagonism on the N-Methyl-D-Aspartate Receptor Channel Complex

10 June 2024

47

1 reference

The competitive NMDA antagonist CGP40.116 enhances L-dopa response in MPTP-treated marmosets

10 June 2024

48

1 reference

10 June 2024

Identifiers

DOI

10.1007/BF02252961

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7605588%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference